Cadrenal Therapeutics (CVKD) Institutional Ownership → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free CVKD Stock Alerts $0.43 +0.01 (+2.38%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cadrenal Therapeutics (NASDAQ:CVKD)CurrentInstitutional OwnershipPercentage7.92%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$668.05KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$420.26K Get CVKD Insider Trade Alerts Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about Cadrenal Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC414,285$307K0.0%-57.8%3.182% 11/15/2023Armistice Capital LLC982,285$668K0.0%N/A7.544% (Data available from 1/1/2016 forward) CVKD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CVKD shares? During the previous two years, the following institutional investors and hedge funds held shares of Cadrenal Therapeutics shares: Armistice Capital LLC ($307K).Learn more on CVKD's institutional investors. What percentage of Cadrenal Therapeutics stock is owned by institutional investors? 7.92% of Cadrenal Therapeutics stock is owned by institutional investors. Learn more on CVKD's institutional investor holdings. Which institutional investors have been buying Cadrenal Therapeutics stock? The following institutional investors have purchased Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($982.29K). How much institutional buying is happening at Cadrenal Therapeutics? Institutional investors have bought a total of 982,285 shares in the last 24 months. This purchase volume represents approximately $668.05K in transactions. Which Cadrenal Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($568K). How much institutional selling is happening at Cadrenal Therapeutics? Institutional investors have sold a total of 568,000 shares in the last 24 months. This volume of shares sold represents approximately $420.26K in transactions. Related Companies: ADIL Institutional Ownership TENX Institutional Ownership CLVR Institutional Ownership TRVN Institutional Ownership ENVB Institutional Ownership CANF Institutional Ownership EFTR Institutional Ownership KZIA Institutional Ownership KA Institutional Ownership BNOX Institutional Ownership This page (NASDAQ:CVKD) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
